OVQATLANISH MADANIYATINI OSHIRISH ORQALI JIGAR KASALLIKLARINING IJTIMOIY YUKINI KAMAYTIRISH
Keywords:
jigar kasalliklari, ovqatlanish madaniyati, surunkali gepatit, yog‘li gepatoz, sog‘lom ovqatlanish, ijtimoiy yuk.Abstract
Ushbu maqolada ovqatlanish madaniyati va surunkali jigar kasalliklari o‘rtasidagi o‘zaro bog‘liqlik, shuningdek, aholining ovqatlanish xatti-harakatlarini sog‘lomlashtirish orqali jigar kasalliklarining ijtimoiy yukini kamaytirish imkoniyatlari tahlil qilinadi. Jahon sog‘liqni saqlash tashkiloti (JSST) ma’lumotlariga ko‘ra, jigar kasalliklari dunyo bo‘yicha o‘lim sabablari orasida yetakchi o‘rinda turadi. Har yili taxminan 1,5 million kishi surunkali gepatit, jigar sirrozi yoki yog‘li gepatoz oqibatida hayotdan ko‘z yumadi(JSST 2024). Tadqiqotda ovqatlanish madaniyati past bo‘lgan hududlarda jigar kasalliklari tarqalishi 1,8–2,4 baravar yuqoriligi aniqlangan. Ilmiy natijalar sog‘lom ovqatlanish, yog‘ va uglevod balansini nazorat qilish, shuningdek, alkogol iste’molini kamaytirish orqali kasallik yukini sezilarli darajada kamaytirish mumkinligini ko‘rsatdi.
Downloads
References
1. Allen AM, Lazarus JV, Younossi ZM. Healthcare and socioeconomic costs of JYG: A global framework to navigate the uncertainties. J Hepatol. 2023 Jul;79(1):209-217. doi: 10.1016/j.jhep.2023.01.026. Epub 2023 Feb 4. PMID: 36740046; PMCID: PMC10293095.
2. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27. PMID: 36990226.
3. Dilkhosh Shamal Ramadhan, Hawler Medical University (Responsible Party), Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients (2024). https://www.clinicaltrials.gov/study/NCT06627114?rank=5&term=AREA%5BBasicSearch%5D(NAFLD%20and%20omega-3)&utm_source=chatgpt.com
4. Global hepatitis report 2024: action for access in low- and middle-income countries, World Health Organization, 9 April 2024
5. Houttu V, Csader S, Nieuwdorp M, Holleboom AG, Schwab U. Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Front Nutr. 2021 Jul 22;8:716783. doi: 10.3389/fnut.2021.716783. PMID: 34368214; PMCID: PMC8339374.
6. Kardashian, AniDodge, Jennifer L.Terrault, Norah A. et al., Quantifying the Negative Impact of Fast-food Consumption on Liver Steatosis Among United States Adults With Diabetes and Obesity, Clinical Gastroenterology and Hepatology, Volume 21, Issue 12, 3176 - 3178.e3
7. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindström T, Nystrom FH; Fast Food Study Group. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut. 2008 May;57(5):649-54. doi: 10.1136/gut.2007.131797. Epub 2008 Feb 14. PMID: 18276725; PMCID: PMC2565580.
8. Manikat, R., Ahmed, A., & Kim, D. (2023). Up-to-date global epidemiology of nonalcoholic fatty liver disease. Hepatobiliary Surgery And Nutrition, 12(6), 956-959. doi:10.21037/hbsn-23-548
9. O'Hara J, Finnegan A, Dhillon H, Ruiz-Casas L, Pedra G, Franks B, Morgan G, Hebditch V, Jönsson B, Mabhala M, Reic T, Van Thiel I, Ratziu V, Romero-Gomez M, Bugianesi E, Schattenberg JM, Anstee QM. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. JHEP Rep. 2020 Jul 15;2(5):100142. doi: 10.1016/j.jhepr.2020.100142. PMID: 32775976; PMCID: PMC7397699.
10. Ufere NN, Satapathy N, Philpotts L, Lai JC, Serper M. Financial burden in adults with chronic liver disease: A scoping review. Liver Transpl. 2022 Dec;28(12):1920-1935. doi: 10.1002/lt.26514. Epub 2022 Jul 7. PMID: 35644920; PMCID: PMC9669101.
11. Xiang, M., Tian, X., Wang, H., Gan, P., & Zhang, Q. (2024). Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity. Nutrients, 16(23), 4208. https://doi.org/10.3390/nu16234208
12. Xiong Yalan, Shi Xinyu, Xiong Xinying, Li Shenyu, Zhao Hanhua, Song Hualing, Wang Jianying, Zhang Lei, You Shengfu, Ji Guang, Liu Baocheng, Wu Na,A systematic review and meta-analysis of randomized controlled trials: effects of mediterranean diet and low-fat diet on liver enzymes and liver fat content of NAFLD, Food & Function 8248-8257, 2024, http://dx.doi.org/10.1039/D4FO01461H
13. Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26. PMID: 27543837.
14. Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (JYG) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3. PMID: 36626630; PMCID: PMC10026948.
15. Zhang Jinghong , Shu Long , Chen Xiaopei, Ultra-processed foods and non-alcoholic fatty liver disease: an updated systematic review and dose–response meta-analysis, Frontiers in Nutrition, Volume 12 - 2025, DOI-10.3389/fnut.2025.1631975
16. Zhang, L., Sui, J., Yin, H., Zhao, Q., Zhou, Y., & Xia, H. (2025). The Impact of the Alternate Mediterranean Diet (aMED) on the Prevention of Chronic Liver Disease: A Meta-Analysis of Observational Studies. Nutrients, 17(18), 2914. https://doi.org/10.3390/nu17182914
17. Zhang, M., Sun, X., Zhu, X. et al. Association between fast eating speed and metabolic dysfunction-associated steatotic liver disease: a multicenter cross-sectional study and meta-analysis. Nutr. Diabetes 14, 61 (2024). https://doi.org/10.1038/s41387-024-00326-x
18. Younossi, Zobair M.1,2,3; Golabi, Pegah1,2,3; Paik, James M.1,2,3; Henry, Austin1; Van Dongen, Catherine1; Henry, Linda1,2,3. The global epidemiology of nonalcoholic fatty liver disease (JYG) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77(4):p 1335-1347, April 2023. | DOI: 10.1097/HEP.0000000000000004
